MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Who Is a TAVR Candidate in 2016?
The assessment of risk and patient selection.
By Robert P. Gooley, MBBS (Hons), and Ian T. Meredith, MBBS (Hons), PhD
Lotus and CoreValve TAVR Systems Compared in 100-Patient Study
June 25, 2015—Findings from a study that aimed to determine whether transcatheter aortic valve replacement (TAVR) with the mechanically expanded Lotus valve (Boston Scientific Corporation) offers potential benefits over treatment with the self-expanding CoreValve (Medtronic plc) were published by Robert P. Gooley, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2015;8:962–971).
Aortic Valve Update & Structural Disease
By Ted E. Feldman, MD, MSCAI, FACC, FESC
